Kaiser Foundation Health Plan Northern California |
hydroxyurea (hydroxyurea) |
Drugs for Cancer : Drugs for Cancer |
- Acute Myeloid Leukemia:
Duration: 1 year(s)
Documented Diagnosis: Yes
Medical Test Required: No
Reauthorization Required: No
Duration of Reauthorization: N/A
Drug Policy Based On: Payer Specific
Quantity Limit: N/A
Diagnosis Types: All FDA-approved indications
Excludes Coverage in Maintenance Setting: No
|